[HTML][HTML] Genetic fusion of CCL11 to antigens enhances antigenicity in nucleic acid vaccines and eradicates tumor mass through optimizing T-cell response

H Qi, Z Sun, T Gao, Y Yao, Y Wang, W Li, X Wang… - Molecular Cancer, 2024 - Springer
Nucleic acid vaccines have shown promising potency and efficacy for cancer treatment with
robust and specific T-cell responses. Improving the immunogenicity of delivered antigens …

[HTML][HTML] Principles and therapeutic applications of adaptive immunity

H Chi, M Pepper, PG Thomas - Cell, 2024 - cell.com
Adaptive immunity provides protection against infectious and malignant diseases. These
effects are mediated by lymphocytes that sense and respond with targeted precision to …

[HTML][HTML] Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade

W Tian, G Qin, M Jia, W Li, W Cai, H Wang… - Frontiers in …, 2023 - frontiersin.org
The fundamental principle of immune checkpoint blockade (ICB) is to protect tumor-
infiltrating T cells from being exhausted. Despite the remarkable success achieved by ICB …

[HTML][HTML] An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy

X Chen, J Zhao, S Yue, Z Li, X Duan, Y Lin, Y Yang… - Nature Cancer, 2024 - nature.com
Tumor-specific T cells are crucial in anti-tumor immunity and act as targets for cancer
immunotherapies. However, these cells are numerically scarce and functionally exhausted …

Lymph node targeting strategy using a hydrogel sustained-release system to load effector memory T cells improves the anti-tumor efficacy of anti-PD-1

H Cui, YY Zhao, YH Han, Z Lan, KL Zou, GW Cheng… - Acta Biomaterialia, 2024 - Elsevier
Communication between tumors and lymph nodes carries substantial significance for
antitumor immunotherapy. Remodeling the immune microenvironment of tumor-draining …

[HTML][HTML] The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma—two sides of the same coin?

R Reschke, B Deitert, AH Enk, JC Hassel - Frontiers in Immunology, 2024 - frontiersin.org
Tissue-resident memory T cells (TRM cells) have become an interesting subject of study for
antitumor immunity in melanoma and other solid tumors. In the initial phases of antitumor …

[HTML][HTML] Targeting the epigenome to reinvigorate T cells for cancer immunotherapy

D Xiong, L Zhang, ZJ Sun - Military Medical Research, 2023 - Springer
Cancer immunotherapy using immune-checkpoint inhibitors (ICIs) has revolutionized the
field of cancer treatment; however, ICI efficacy is constrained by progressive dysfunction of …

[HTML][HTML] A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer

PZ Han, WD Ye, PC Yu, LC Tan, X Shi, XF Chen, C He… - JCI insight, 2024 - ncbi.nlm.nih.gov
Both anaplastic thyroid cancer (ATC) and papillary thyroid cancer (PTC) originate from
thyroid follicular epithelial cells, but ATC has a significantly worse prognosis and shows …

Regulation and immunotherapeutic targeting of the epigenome in exhausted CD8 T cell responses

BR Ford, AC Poholek - The Journal of Immunology, 2023 - journals.aai.org
Exhaustion is a state of CD8 T cell differentiation that occurs in settings of chronic Ag such
as tumors, chronic viral infection, and autoimmunity. Cellular differentiation is driven by a …

[HTML][HTML] Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancer

C Yan, H Huang, Z Zheng, X Ma, G Zhao… - Frontiers in …, 2023 - frontiersin.org
Background The spatial distribution of tumor-infiltrating T cells and its dynamics during
chemoradiotherapy combined with PD-1 blockade is little known in esophageal squamous …